A Study of LY3437943 in Participants With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

281

Participants

Timeline

Start Date

May 13, 2021

Primary Completion Date

July 8, 2022

Study Completion Date

October 27, 2022

Conditions
Type 2 Diabetes
Interventions
DRUG

LY3437943

Administered SC

DRUG

Dulaglutide

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (43)

674

Manati Center for Clinical Research, Manatí

909

Latin Clinical Trial Center, San Juan

15009

Heritage Valley Medical Group, Inc., Beaver

15236

Preferred Primary Care Physicians, Pittsburgh

15401

Preferred Primary Care Physicians, Uniontown

15478

Frontier Clinical Research, LLC, Smithfield

21075

Centennial Medical Group, Elkridge

29607

The Research Center of The Upstate, Greenville

33063

South Florida Clinical Research Institute, Margate

33331

Encore Medical Research - Weston, Weston

33613

ForCare Clinical Research, Tampa

35660

Syed Research Consultants Llc, Sheffield

39465

MediSync Clinical Research, Petal

50265

Iowa Diabetes and Endocrinology Research Center, West Des Moines

58104

Lillestol Research, Fargo

59901

Logan Health Research, Kalispell

65810

Clinvest Research LLC, Springfield

66606

Cotton O'Neil Clinic, Topeka

73069

Intend Research, LLC, Norman

75149

Southern Endocrinology Associates, Mesquite

75230

Dallas Diabetes Research Center, Dallas

76132

Diabetes and Thyroid Center of Fort Worth, Fort Worth

76180

North Hills Family Medicine/North Hills Medical Research, North Richland Hills

77079

Endocrine Ips, Pllc, Houston

77089

Laila A Hassan, MD, PA, Houston

83221

Elite Clinical Trials, Blackfoot

83404

Rocky Mountain Clinical Research, Idaho Falls

83440

Elite Clinical Trials, Rexburg

83702

Humphreys Diabetes Center, Boise

90255

National Research Institute - Huntington Park, Huntington Park

91304

San Fernando Valley Health Institute, Canoga Park

91402

National Research Institute - Panorama City, Panorama City

91763

Catalina Research Institute, LLC, Montclair

92103

Artemis Institute for Clinical Research, San Diego

92374

Anderson Clinical Research, Redlands

92503

Artemis Institute for Clinical Research, Riverside

92704

National Research Institute (NRI) - Santa Ana, Santa Ana

93720

Valley Endocrine, Fresno, Fresno

94598

Diablo Clinical Research, Inc., Walnut Creek

98057

Rainier Clinical Research Center, Renton

98405

Universal Research Group, Tacoma

98664

The Vancouver Clinic, Vancouver

00961

Advanced Clinical Research, LLC, Bayamón

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY